Loratadine and Cefprozil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loratadine (loratadine) and Cefprozil (cefprozil). Common drug interactions include fluid retention among females and chronic myeloid leukaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Loratadine and Cefprozil. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Loratadine?

Loratadine has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 56,314 Loratadine users. Check the latest studies of Loratadine.

What is Cefprozil?

Cefprozil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,103 Cefprozil users. Check the latest studies of Cefprozil.



On Jul, 20, 2026

32 people who take Loratadine and Cefprozil together, and have interactions are studied.

Loratadine and Cefprozil drug interactions.

What are the common drug interactions of Loratadine and Cefprozil, by gender? *:

female:

  1. Fluid retention (an abnormal accumulation of fluid in the blood)
  2. Food intolerance (inability to have food)
  3. Renal injury (kidney injury)
  4. Stress
  5. Suicidal ideation
  6. Anxiety
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Depression
  9. Dry mouth
  10. Dysphagia (a condition in which swallowing is difficult or painful)

male:

  1. Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
  2. Swelling
  3. Diarrhoea
  4. Ear infection
  5. Fatigue (feeling of tiredness)
  6. Muscle spasms (muscle contraction)
  7. Nephrolithiasis (calculi in the kidneys)
  8. Oropharyngeal pain
  9. Pain
  10. Renal impairment (severely reduced kidney function)

What are the common drug interactions of Loratadine and Cefprozil, by age (0-1 to 60+)? *:

0-1:

  1. Hospitalisation
  2. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  3. Hypophagia (reduced food intake)
  4. Hypotonia (low muscle tone)
  5. Hypoxia (low oxygen in tissues)
  6. Immunodeficiency
  7. Infection susceptibility increased
  8. Ingrowing nail
  9. Klebsiella infection
  10. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease

40-49:

  1. Chronic kidney disease
  2. Pain
  3. Anxiety
  4. Arthralgia (joint pain)
  5. Back pain
  6. Dizziness
  7. Ear infection
  8. Emotional distress
  9. Fatigue (feeling of tiredness)
  10. Nephrolithiasis (calculi in the kidneys)

50-59:

  1. Chronic kidney disease
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Blood potassium decreased
  4. Drug ineffective
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Food intolerance (inability to have food)
  7. Loss of consciousness
  8. Peripheral swelling
  9. Renal failure (kidney dysfunction)
  10. Stress

60+:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Oesophageal stenosis (narrowing of oesophagus)
  4. Renal injury (kidney injury)
  5. Renal pain (kidney pain)
  6. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  7. Anxiety
  8. Back pain
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Depression

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 43.75%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 12 people, 37.50%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 37.50%
  4. Pain: 10 people, 31.25%
  5. Infection: 9 people, 28.12%
  6. Fluid Retention (an abnormal accumulation of fluid in the blood): 7 people, 21.88%
  7. High Blood Pressure: 7 people, 21.88%
  8. Nausea (feeling of having an urge to vomit): 6 people, 18.75%
  9. Urinary Tract Infection: 6 people, 18.75%
  10. Stress And Anxiety: 6 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Loratadine and Cefprozil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loratadine and Cefprozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loratadine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefprozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loratadine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefprozil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loratadine and cefprozil (the active ingredients of Loratadine and Cefprozil, respectively), and Loratadine and Cefprozil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: